Roche’s Atezolizumab receives DCGI approval for treatment of metastatic triple-negative breast… EP News Bureau Apr 8, 2020 Atezolizumbab is the first immunotherapy drug to be approved globally for treatment of unresectable locally advanced and…
Invictus Oncology to present data on IO-125 at Breast Cancer Symposium Sanjiv Das Sep 24, 2015 IO-125, a novel supramolecular platinum chemotherapy, is being developed in Triple-Negative Breast Cancer (TNBC) Invictus…
